secwatch.observer — SEC 8-K summary
======================================

Issuer:     XWELL, Inc. (XWEL)
CIK:        0001410428
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001104659-24-061978
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

XWELL Q1 revenue up 24% to $8.7M; operating loss narrows 62% to $2.4M
---------------------------------------------------------------------

- Revenue $8.7M vs $7.1M YoY; XpresSpa/Treat $4.4M, XpresTest $3.6M, Naples Wax $0.6M.
- Operating loss improved 62% to $2.4M; net loss $2.5M vs $5.5M.
- Cash $4.3M, marketable securities $14.8M; no long-term debt.
- CDC TGS program expanded to Miami/Chicago; estimated funding increased to $36.7M.
- Plans to open 3 new Naples Wax Centers in 2024 and XpresSpa at NYC Penn Station this summer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1410428/000110465924061978/0001104659-24-061978-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1410428/000110465924061978/tm2414488d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-061978

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer